Skip to main content
Premium Trial:

Request an Annual Quote

Canopy Biosciences RareSeq

Canopy Biosciences has launched its RareSeq error corrected sequencing service. The technology removes errors generated during next generation sequencing to separate rare mutations from background noise. Canopy is launching the service with a panel of genetic variants linked to myeloid diseases, aiming to offer users a tool to study to study disease development, progression, and recurrence. The firm said that the panel targets 54 genes that are often mutated in myeloid malignancies.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.